The European Commission has approved a Lithuanian scheme, worth 61 million euros, to support research and development (R&D) of products to tackle the coronavirus pandemic.
The aim of the scheme is to enhance and accelerate the development of medicinal products including vaccines, hospital and medical equipment including ventilators, protective clothing and equipment, diagnostic tools, disinfectants and data collection and processing tools.
The scheme had been approved under the State Aid Temporary Framework, the Commission said in a press release.
The scheme will be open to enterprises except for companies primarily working in the agriculture, fishery and aquaculture, and financial sectors. The public support will take the form of direct grants.